Skip to search.
 BSE Down0.25% NSE Down0.32%

AstraZeneca PLC (AZN)

-NYSE

52.35 Up 0.64(1.24%) 1:32AM

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Dec-201231-Dec-201131-Dec-2010
Total Revenue 27,973,000   33,591,000   33,269,000  
Cost of Revenue5,393,000  6,026,000  6,389,000  
Gross Profit 22,580,000   27,565,000   26,880,000  
Operating Expenses
Research Development5,243,000  5,523,000  5,318,000  
Selling General and Administrative9,189,000  10,730,000  10,068,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 8,148,000   12,795,000   11,494,000  
Income from Continuing Operations
Total Other Income/Expenses Net528,000  2,035,000  516,000  
Earnings Before Interest And Taxes8,676,000  13,347,000  12,010,000  
Interest Expense958,000  980,000  1,033,000  
Income Before Tax7,718,000  12,367,000  10,977,000  
Income Tax Expense1,391,000  2,351,000  2,896,000  
Minority Interest -   -   -  
Net Income From Continuing Ops6,327,000  10,016,000  8,081,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 6,327,000   10,016,000   8,081,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 6,327,000   10,016,000   8,081,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.